Oncology News | pharmaphorum

News

Immunocore hires Lilly's Hotchkiss as chief commercial offic...

UK biotech leading in the nascent field of TCR immunotherapy has appointed Andrew Hotchkiss as its new Chief Commercial Officer.

News

Endocyte bounces back with late-stage prostate cancer deal

Endocyte saw its share price take off after acquiring rights to a promising late-stage cancer therapy.

News

Following FDA encouragement, Faron’s orphan drug gets UK spe...

Faron Pharmaceuticals has been granted a Promising Innovative Medicines (PIM) designation in the UK for its lead product Traumakine, currently in phase 3 trials for Acute Respiratory Distre

Immunocore hires Lilly's Hotchkiss as chief commercial offic...

Endocyte bounces back with late-stage prostate cancer deal

Following FDA encouragement, Faron’s orphan drug gets UK spe...

Patients not just at the table, but creating their own: In c...

Securing your ROI: Turning post-acquisition integration into...

News

Editor's Picks